Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 1139-1148

  Chen, Xiaoyu ^a   Huang, Wenhua ^a   Kwan Wong, Blenda Chi ^a   Yin, Linlin ^a   Wong, Yuen Fan ^a   Xu, Min ^a   Yang, Zhijun ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Asthma; Intratracheal administration; Salbutamol sulfate; Sustained release

Indexed keywords

LIPOSOME; SALBUTAMOL SULFATE; ANTIASTHMATIC AGENT; DRUG CARRIER; FLUORESCENT DYE; HISTAMINE; SALBUTAMOL;

AEROSOL; ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANURA; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG LUNG LEVEL; DRUG PENETRATION; DRUG RETENTION; DRUG SOLUBILITY; DRUG TISSUE LEVEL; DRUG TRANSPORT; ENCAPSULATION; ENCAPSULATION EFFICIENCY; GUINEA PIG; IN VITRO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PARTICLE SIZE; PHARMACODYNAMICS; PULMONARY DRUG DELIVERY SYSTEM; RAT; SUSTAINED DRUG RELEASE; TIME TO MAXIMUM PLASMA CONCENTRATION; ANALYSIS OF VARIANCE; ANIMAL; ASTHMA; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DELAYED RELEASE FORMULATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; METABOLISM; PERMEABILITY; SPRAGUE DAWLEY RAT; STATISTICAL MODEL;

ANIMALIA; ANURA; CAVIA; RATTUS;

ADMINISTRATION, INHALATION; ALBUTEROL; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ASTHMATIC AGENTS; ANURA; ASTHMA; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FLUORESCENT DYES; GUINEA PIGS; HISTAMINE; LINEAR MODELS; LIPOSOMES; LUNG; MALE; PARTICLE SIZE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84862315073     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S28011     Document Type: Article

References (39)

1. Eagan TM, Brøgger JC, Eide GE, Bakke PS. The incidence of adult asthma: a review. Int J Tuberc Lung Dis. 2005;9(6):603-612.
2. Bryan J. Ventolin remains a breath of fresh air for asthma sufferers, after 40 years. Pharm J. 2007;279(7473):404-405.
3. Kelly HW, Murphy S. Beta-adrenergic agonists for acute, severe asthma. Ann Pharmacother. 1992;26(1):81-91.
4. Liisa ML, Kirsi P, Kaarina K, Seija Tammilehto. Decomposition of salbutamol in aqueous solutions. II. The effect of buffer species, pH, buffer concentration and antioxidants. Int J Pharm. 1995;117(2): 189-195.
5. Nizet TA, Broeders ME, Folgering HT. Tremor side effects of salbutamol, quantified by a laser pointer technique. Respir Med. 2004;98(9): 844-850.
6. Bendas ER, Tadros MI. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS Pharm Sci Tech. 2007;8(4):E07.
7. Sweetman SC. Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press; 2005.
8. Liu FY, Shao Z, Kildsig DO, Mitra AK. Pulmonary delivery of free and liposome insulin. Pharm Res. 1993;10(2):228-232.
9. Beyer J, Barzen G, Risse G, et al. Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis. Antimicrob Agents Chemother. 1993;37(6):1367-1371.
10. Gavalda J, Martin MT, Lopez P, et al. Efficacy of nebulized liposome amphotericin B in treatment of experimental pulmonary aspergillosis. Antimicrob Agents Chemother. 2005;49(7):3028-3030.
11. Okumura K, Iwakawa S, Yoshida T, Seki T, Komada F. Intratracheal delivery of insulin and adsorption from solution and aerosol by rat lung. Int J Pharm. 1992;88(1-3):63-73.
12. Yamamoto A, Umemori S, Muranishi S. Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rat. J Pharm Pharmacol. 1994;46(1):14-18.
13. Poyner EA, Alpar HO, Almeida AJ, et al. A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery. J Control Release. 1995;35(1):41-48.
14. Ten RM, Anderson PM, Zein NN, Temesgen Z, Clawson ML, Weiss W. Interleukin-2 liposomes for primary immune deficiency using the aerosol route. Int Immunopharmacol. 2002;2(2-3):333-344.
15. Edwards D, Hanes J, Caponetti G, et al. Large porous aerosols for pulmonary drug delivery. Science. 1997;276(5320):1868-1871.
16. Saari M, Vidgren MT, Koskinen MO, Turjanmaa VM, Nieminen MM. Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. Int J Pharm. 1999;181(1):1-9.
17. Huang YY, Wang CH. Pulmonary delivery of insulin by liposomes. J Control Release. 2006;113(1):9-14.
18. Brandl M, Massing U. Vesicular phospholipid ges. In: Torchilin VP, Weissig V, editors. Liposomes. 2nd ed. New York: Oxford Press; 2003: 353-372.
19. Yang ZJ, Fong DWE, Yin LL, Wong Y, Huang W. Liposomes modulate docetaxel-induced lipod oxidization and membrane damage in human hepatoma cells. J Liposome Res. 2009;19(2):122-130.
20. Zhigaltsec IV, Maurer N, Edwards K, Karlsson G, Cullis PR. Formation of drug-arylsulfonate complexes inside liposomes: A novel approach to improve drug retention. J Control Rel. 2006;110(2):378-386.
21. Wall DA, Pierdomenico D, Wilson G. An in vitro pulmonary epithelial system for evaluating peptide transport. J Control Rel. 1993;24(1-3): 227-235.
22. Okumura S, Fukuda Y, Takahashi K, Fujita T, Yamamoto A, Muranishi S. Transport of drugs across the Xenopus pulmonary membrane and their absorption enhancement by various absorption enhancers. Pharm Res. 1996;13(8):1247-1251.
23. Liu Y, Lu WL, Hu X, et al. Transport of Recombinant hirudin across Xenopus pulmonary membrane. Chin Pharm J. 2005;39(17): 1318-1322.
24. Vogel HG. Bronchospasmolytic activity in anesthetized guinea pigs. In: Vogel H, editor. Drug Discovery and Evaluation: Pharmacological Assays. 2nd ed. New York: Springer; 2002:359-360.
25. Nogami-Itoh M, Yakuo I, Hammerbeck DM, Miller RL, Takeyama K. The equivalent bronchodilator effects of salbutamol formulated in chlorofluorocarbon and hydrofluoroalkane-134a metered dose inhalers on the histamine-induced pulmonary response in dogs. Pharm Res. 1997;14(2): 208-212.
26. Venables KM, Dally MB, Burge PS, Pickering CA, Nerman Taylor AJ. Occupational asthma in a steel coating plant. B J Ind Med. 1985; 42(8):517-524.
27. Brandl M, Achmann BD, Drechsler M, Bauer KH. Liposome preparation by a new high pressure homogenizer Gaulin Micron Lab 40. Drug Dev Ind Pharm. 1990;16(14):2167-2191.
28. Kaiser N, Kimpfler A, Massing U, et al. 5-Fluoroacil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties. Int J Pharm. 2003;256(1-):123-131.
29. Brandl M, Drechsler M, Bachmann D, Tardi C, Schmidtgen M, Bauer KH. Preparation and characterisation of semisolid phospholipid dispersions and dilutions thereof. Int J Pharm. 1998;170(2):187-199.
30. Brandl M, Reszka R. Preparation and characterisation of phospholipid membrane gels as depot formulations for potential use as implants. Proc Int Symp Control Release Bioact Mater. 1995;22:472-473.
31. Brandl M, Drechsler M, Bachmann D, Bauer KH. Morphology of semisolid aqueous phosphatidylcholine dispersions, a freeze fracture electron microscopy study. Chem Phys Lipids. 1997;87(1):65-72.
32. Brandl M, Tardi C, Drechsler M, et al. Three-dimensional liposome networks: freeze fracture electron microscopical evaluation of their structure and in-vitro analysis of release of hydrophilic markers. Adv Drug Deliv Rev. 1997;24(2-3):161-164.
33. Kalchenko V, Shivtiel S, Malina V, et al. Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing. J Biomed Opt. 2006;11(5):050507.
34. Vladimir T, Volkmar W. Liposomes: A Practical Approach. 2nd ed. New York: Oxford University Press; 2003.
35. Juliano RL, McCullough HN. Controlled delivery of an antitumor drug: localized action of liposome encapsulated cytosine arabinoside administered via the respiratory system. J Pharmacol Exp Ther. 1980;214(2): 381-387.
36. Taylor KM, Taylor G, Kellaway IW, Stevens J. The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. Pharm Res. 1989;6(7):633-636.
37. Rao J, Dragulescu-Andrasi A, Yao H. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol. 2007;181(1):17-25.
38. Lipworth BJ, Clark DJ. Lung delivery of salbutamol by dry powder inhaler (Turbuhaler®) and small volume antistatic metal spacer (Airomir® CFC-free MDI plus NebuChamber®). Eur Respir J. 1997;10(8):1820-1823.
39. Yuji T, Hirokazu K, Ryuta H, et al. Roles of histamine receptor in a guinea pigs asthma model. Int J Immunopharmacol. 1998;20(10): 565-571.